Efficacy and safety of )a) Artemether-lumefantrine (b) Dihydroartemisinin piperaquine phosphate for the treatment of uncomplicated Plasmodium falciparum malaria in Tamu Township, Sagaing Regio

Not Applicable

• Conditions: malaria related fever; headache; Infection - Other infectious diseases; malaise; malaria; loss of appetite

• Registration Number: ACTRN12619000937112
• Lead Sponsor: World Health Organization

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-05
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Patients having fever with a parasitological count of 1000 asexual parasite count per 1 ul of blood for P falciparum malaria and 500 asexual parasite count per 1 ul of blood for P. vivax malaria

Exclusion Criteria

Patients having severe and complicated malaria

Study & Design

• Study Type: Interventional
• Study Design: Not specified